The effect of Mud Lepa in rheumatoid arthritis
- Conditions
- Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor
- Registration Number
- CTRI/2024/05/067340
- Lead Sponsor
- ational Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients aged 18 to 60 years of either sex
Confirmed and diagnosed cases of Rheumatoid Arthritis based on established criteria e g American College of Rheumatology/European League Against Rheumatism criteria
Active disease status as indicated by a Disease Activity Score DAS28 of more than or equal to 3 point 2
Chronic cases up to 5 years
Pregnant or lactating individuals due to potential risks associated with the treatments
Known contraindications or allergy to any of the study drugs contents or Mritika Lepa
Presence of significant comorbidities such as uncontrolled diabetes hypertension renal or hepatic impairment which may interfere with the assessment of study outcomes
Coexistence of other autoimmune diseases
e g systemic lupus erythematosus that may confound the assessment of Rheumatoid Arthritis outcomes
Severe joint damage or deformities that may limit accurate pain assessment or interfere with the treatment outcomes
Use of systemic immunosuppressive agents within the last three months prior to enrolment
Recent major surgery within the last three months that may impact the study outcomes
Participation in another clinical trial within 30 days before screening
Inability to comply with the study procedures or follow-up visits
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method